Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-termmal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction

American Journal of Cardiology

Volumn 77, Issue 10, 1996, Pages 828-831

  Davidson, Neil C ^a   Naas, Abdelwahab A ^a   Hanson, Jacqueline K ^a   Kennedy, Norman S J ^a   Coutie, Wendy J ^a   Struthers, Allan D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FUNCTION; HEART VENTRICULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; FEMALE; GATED BLOOD-POOL IMAGING; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROTEIN PRECURSORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0029885046     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)89176-X     Document Type: Article

References (9)

1. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203.
2. Nakao K, Ogawa Y, Suga S, Imura H. Molecular biology and biochemistry of the natriuretic peptide system I: natriuretic peptides. J Hypertens 1992;10:907-912.
3. Yandle TG, Richards AM, Gilbert A, Fisher S, Holmes S, Espiner EA. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for a high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 1993;76:832-838.
4. Wei C, Heublein DM, Perrella MA, Lerman A, Rodeheffer RJ, McGregor CGA, Edwards WD, Schaff HV, Burnett JC Jr. Natriuretic peptide system in human heart failure. Circulation 1993;88:1004-1009.
5. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
6. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD. Echocardiography in chronic heart failure in the community. Q J Med 1993;86:17-23.
7. Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, McKinley LJ, Heublein DM, Burnett JC Jr. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341:1105-1109.
8. Buckley MG, Sagnella GA, Markandu ND, Singer DR, MacGregor GA. Concentrations of N-terminal proANP in human plasma: evidence for proANP (1-98) as the circulating form. Clin Chim Acta 1990;191:1-14.
9. Holmes SJ, Espiner EA, Richards AM, Yandle TG, Frampton C. Renal, endocrine and haemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993;76:91-96.